Price T Rowe Associates Inc Maravai Lifesciences Holdings, Inc. Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
A detailed history of Price T Rowe Associates Inc transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 62,882 shares of MRVI stock, worth $311,894. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62,882
Previous 61,863
1.65%
Holding current value
$311,894
Previous $443,000
18.06%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding MRVI
# of Institutions
235Shares Held
141MCall Options Held
223KPut Options Held
19.4K-
Gtcr LLC20.2MShares$99.9 Million13.05% of portfolio
-
12 West Capital Management LP New York, NY14MShares$69.5 Million12.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$58.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$48.3 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$41.4 Million1.97% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $652M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...